{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:42:53Z","timestamp":1760182973051,"version":"build-2065373602"},"reference-count":72,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.rdc.2008.08.008","type":"journal-article","created":{"date-parts":[[2008,11,10]],"date-time":"2008-11-10T03:17:21Z","timestamp":1226287041000},"page":"987-1000","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Treatment of Dry Eye Disease by the Non-Ophthalmologist"],"prefix":"10.1016","volume":"34","author":[{"given":"Gary N.","family":"Foulks","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.rdc.2008.08.008_bib1","first-page":"1","article-title":"The report of the international dry eye workshop","volume":"5","author":"DEWS Group","year":"2007","journal-title":"Ocul Surf"},{"key":"10.1016\/j.rdc.2008.08.008_bib2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1542-0124(12)70081-2","article-title":"Report of the international dry eye workshop. Definition and classification of dry eye","volume":"5","year":"2007","journal-title":"Ocul Surf"},{"key":"10.1016\/j.rdc.2008.08.008_bib3","first-page":"221","article-title":"Report of the National Eye Institute\/Industry Workshop on clinical trials in dry eye","volume":"21","author":"Lemp","year":"1995","journal-title":"CLAO J"},{"key":"10.1016\/j.rdc.2008.08.008_bib4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1542-0124(12)70085-X","article-title":"Report of the international dry eye workshop. Management and therapy of dry eye disease","volume":"5","year":"2007","journal-title":"Ocul Surf"},{"key":"10.1016\/j.rdc.2008.08.008_bib5","first-page":"151","article-title":"Sj\u00f6gren's syndrome and tear function parameters","volume":"7","author":"van Bijsterveld","year":"1989","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2008.08.008_bib6","first-page":"766","article-title":"The frequency of sicca syndrome in an elderly female population","volume":"14","author":"Strickland","year":"1987","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2008.08.008_bib7","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/archopht.122.3.369","article-title":"Incidence of dry eye in an older population","volume":"122","author":"Moss","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.rdc.2008.08.008_bib8","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0002-9394(14)71688-5","article-title":"Prevalence of dry eye among the elderly","volume":"124","author":"Schein","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.rdc.2008.08.008_bib9","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0002-9394(03)00218-6","article-title":"Prevalence of dry eye syndrome among US women","volume":"136","author":"Schaumberg","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.rdc.2008.08.008_bib10","first-page":"17","article-title":"Sex hormones and Sj\u00f6gren's syndrome","volume":"24","author":"Sullivan","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2008.08.008_bib11","first-page":"S276","article-title":"Are women with Sj\u00f6gren's syndrome androgen deficient?","volume":"41","author":"Sullivan","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.rdc.2008.08.008_bib12","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1001\/archopht.118.9.1264","article-title":"Prevalence of and risk factors for dry eye syndrome","volume":"118","author":"Moss","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.rdc.2008.08.008_bib13","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1442-9071.2003.00634.x","article-title":"Prevalence and associations of dry eye syndrome in an older population: the Blue Mountains Eye Study","volume":"31","author":"Chia","year":"2003","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.rdc.2008.08.008_bib14","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/01.OPX.0000156310.45736.FA","article-title":"Prevalence and severity of symptomatic dry eyes in Hispanics","volume":"82","author":"Hom","year":"2005","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.rdc.2008.08.008_bib15","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1136\/bjo.86.12.1347","article-title":"Prevalence and risk factors associated with dry eye symptoms: a population based study in Indonesia","volume":"86","author":"Lee","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.rdc.2008.08.008_bib16","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0161-6420(03)00262-8","article-title":"Prevalence of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study","volume":"110","author":"Lin","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.rdc.2008.08.008_bib17","first-page":"1","article-title":"State-of-the-art management of chronic dry eye. A growing public health concern","volume":"24","year":"2006","journal-title":"Clinician"},{"key":"10.1016\/j.rdc.2008.08.008_bib18","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1001\/archopht.1979.01020020210003","article-title":"Tear osmolarity and ocular surface disease in keratoconjunctivitis sicca","volume":"97","author":"Gilbard","year":"1979","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.rdc.2008.08.008_bib19","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0161-6420(84)34163-X","article-title":"Morphologic effect of hyperosmolarity on rabbit corneal epithelium","volume":"91","author":"Gilbard","year":"1984","journal-title":"Ophthalmology"},{"key":"10.1016\/j.rdc.2008.08.008_bib20","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/01.ICL.0000162759.79740.46","article-title":"Hyperosmolar saline is a proinflammatory stress on the mouse ocular surface","volume":"31","author":"Luo","year":"2005","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.rdc.2008.08.008_bib21","first-page":"2609","article-title":"Conjunctival T-cell subpopulations in Sj\u00f6gren's and non-Sj\u00f6gren's patients with dry eye","volume":"43","author":"Stern","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.rdc.2008.08.008_bib22","first-page":"1356","article-title":"Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes","volume":"41","author":"Brignole","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.rdc.2008.08.008_bib23","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/978-1-4615-0717-8_91","article-title":"Experimentally induced dry eye produces ocular surface inflammation and epithelial disease","volume":"506","author":"Dursun","year":"2002","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.rdc.2008.08.008_bib24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1076\/ceyr.19.3.201.5309","article-title":"Altered cytokine balance in the tear fluid and conjunctiva of patients with Sj\u00f6gren's syndrome keratoconjunctivitis sicca","volume":"19","author":"Pflugfelder","year":"1999","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.rdc.2008.08.008_bib25","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1167\/iovs.03-1145","article-title":"Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signalling pathways on the ocular surface","volume":"45","author":"Luo","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.rdc.2008.08.008_bib26","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0161-6420(99)90171-9","article-title":"Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sj\u00f6gren's syndrome","volume":"106","author":"Marsh","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.rdc.2008.08.008_bib27","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ajo.2004.04.052","article-title":"A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance","volume":"138","author":"Pflugfelder","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.rdc.2008.08.008_bib28","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0161-6420(00)00035-X","article-title":"Efficacy and safety of cyclosporin a ophthalmic\u00a0emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group","volume":"107","author":"Stevenson","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.rdc.2008.08.008_bib29","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0161-6420(99)00176-1","article-title":"Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group","volume":"107","author":"Sall","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.rdc.2008.08.008_bib30","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1001\/archopht.118.11.1489","article-title":"Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes","volume":"118","author":"Kunert","year":"2000","journal-title":"Arch Ophthalmol"},{"issue":"Supp2","key":"10.1016\/j.rdc.2008.08.008_bib31","first-page":"1","article-title":"Zur kenntnis der keratoconjunctivitis sicca (Keratitis filiformis bei Hypofunktion der Tranendrusen)","author":"Sjogren","year":"1933","journal-title":"Acta Ophthalmol (Kbh)"},{"key":"10.1016\/j.rdc.2008.08.008_bib32","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/00003226-199811000-00002","article-title":"The pathology of dry eye: the interaction between the ocular surface and lacrimal glands","volume":"17","author":"Stern","year":"1998","journal-title":"Cornea"},{"key":"10.1016\/j.rdc.2008.08.008_bib33","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S1542-0124(12)70148-9","article-title":"Inflammation in dry eye","volume":"2","author":"Stern","year":"2004","journal-title":"Ocul Surf"},{"key":"10.1016\/j.rdc.2008.08.008_bib34","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/S0161-6420(98)98033-2","article-title":"Meibomian gland dysfunction in patients with Sjogren syndrome","volume":"105","author":"Shimazaki","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.rdc.2008.08.008_bib35","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.ajo.2005.12.047","article-title":"Smoking associated with damage to the lipid layer of the ocular surface","volume":"141","author":"Altinors","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.rdc.2008.08.008_bib36","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s00417-003-0845-z","article-title":"Marked reduction and distinct patterns of eye blinking in patients with moderately dry eyes during video display terminal use","volume":"242","author":"Schlote","year":"2004","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.rdc.2008.08.008_bib37","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/01.ico.0000214802.40313.fa","article-title":"Dysfunctional tear syndrome: a Delphi approach to treatment recommendations","volume":"25","author":"Behrens","year":"2006","journal-title":"Cornea"},{"key":"10.1016\/j.rdc.2008.08.008_bib38","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/978-1-4615-5359-5_99","article-title":"Classification of artificial tears. I: composition and properties","volume":"438","author":"Murube","year":"1998","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.rdc.2008.08.008_bib39","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/978-1-4615-5359-5_100","article-title":"Classification of artificial tears, II: additives and commercial formulas","volume":"438","author":"Murube","year":"1998","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"10.1016\/j.rdc.2008.08.008_bib40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00004397-199403410-00005","article-title":"Human tear film electrolyte concentrations in health and dry-eye disease","volume":"34","author":"Gilbard","year":"1994","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.rdc.2008.08.008_bib41","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0161-6420(92)31929-3","article-title":"An electrolyte-based solution that increases corneal glycogen and conjunctival goblet cell density in a rabbit model for keratoconjunctivitis sicca","volume":"99","author":"Gilbard","year":"1992","journal-title":"Ophthalmology"},{"key":"10.1016\/j.rdc.2008.08.008_bib42","first-page":"236","article-title":"Effect of nonisotonic solutions on tear film osmolality","volume":"20","author":"Holly","year":"1981","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.rdc.2008.08.008_bib43","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1076\/ceyr.28.1.55.23495","article-title":"Clinical evaluation of an HP-guar gellable lubricant eye drop for the relief of dryness of the eye","volume":"28","author":"Christensen","year":"2004","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.rdc.2008.08.008_bib44","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ophtha.2003.07.008","article-title":"Sequential changes of lipid tear film after the\u00a0instillation of a single drop of a new emulsion eye drop in dry eye patients","volume":"111","author":"Di Pascuale","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.rdc.2008.08.008_bib45","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/01.opx.0000171818.01353.8c","article-title":"The effect of two novel lubricant eye drops on tear film lipid layer thickness in subjects with dry eye symptoms","volume":"82","author":"Korb","year":"2005","journal-title":"Optom Vis Sci"},{"issue":"4566","key":"10.1016\/j.rdc.2008.08.008_bib46","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1126\/science.7112124","article-title":"Living with water stress: evolution of osmolyte systems","volume":"217","author":"Yancey","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.rdc.2008.08.008_bib47","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1242\/jeb.01730","article-title":"Organic osmolytes as compatible, metabolic and counteracting cryoprotectants in high osmolarity and other stresses","volume":"208","author":"Yancey","year":"2005","journal-title":"J Exp Biol"},{"issue":"10","key":"10.1016\/j.rdc.2008.08.008_bib48","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.ophtha.2005.05.013","article-title":"Phase 3 safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years","volume":"112","author":"Barber","year":"2005","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.rdc.2008.08.008_bib49","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1089\/10807680260362696","article-title":"Blood concentrations of cyclosporine a during long-term treatment with cyclosporine a ophthalmic emulsions in patients with moderate to severe dry eye disease","volume":"18","author":"Small","year":"2002","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.rdc.2008.08.008_bib50","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2165\/00003088-200544030-00003","article-title":"Ocular pharmacokinetics and safety of ciclosporin, a novel topical treatment for dry eye","volume":"44","author":"Tang-Liu","year":"2005","journal-title":"Clin Pharmacokinet"},{"issue":"9 Suppl 1","key":"10.1016\/j.rdc.2008.08.008_bib51","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/ICO.0b013e31812f6782","article-title":"Management of ocular surface inflammation in Sj\u00f6gren syndrome","volume":"26","author":"Hyon","year":"2007","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.rdc.2008.08.008_bib52","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/01.ico.0000133994.22392.47","article-title":"Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca","volume":"24","author":"Strong","year":"2005","journal-title":"Cornea"},{"key":"10.1016\/j.rdc.2008.08.008_bib53","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archopht.120.3.330","article-title":"Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine","volume":"120","author":"Kunert","year":"2002","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.rdc.2008.08.008_bib54","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00003226-198801000-00012","article-title":"Impression cytology","volume":"7","author":"Nelson","year":"1988","journal-title":"Cornea"},{"key":"10.1016\/j.rdc.2008.08.008_bib55","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/00003226-200111000-00019","article-title":"Quantification of MUC5AC protein in human tears","volume":"20","author":"Zhao","year":"2001","journal-title":"Cornea"},{"key":"10.1016\/j.rdc.2008.08.008_bib56","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1080\/15027732.1986.12461420","article-title":"Essential fatty acid and prostaglandin metabolism in Sj\u00f6gren's syndrome, systemic sclerosis, and rheumatoid arthritis","volume":"61","author":"Horrobin","year":"1986","journal-title":"Scand J Rheumatol Suppl"},{"key":"10.1016\/j.rdc.2008.08.008_bib57","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/ajcn\/82.4.887","article-title":"Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women","volume":"82","author":"Miljanovic","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.rdc.2008.08.008_bib58","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00003226-200303000-00002","article-title":"Systemic linoleic and gamma-linolenic acid therapy in dry eye syndrome with an inflammatory component","volume":"22","author":"Barabino","year":"2003","journal-title":"Cornea"},{"key":"10.1016\/j.rdc.2008.08.008_bib59","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/archophthalmol.2007.61","article-title":"Topical omega-3 and omega-6 fatty acids for treatment of dry eye","volume":"126","author":"Rashid","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.rdc.2008.08.008_bib60","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/978-1-4615-5359-5_140","article-title":"Oral pilocarpine for symptomatic relief of keratoconjunctivitis sicca in patients with Sj\u00f6gren's syndrome. The MGI Pharma Sj\u00f6gren's Syndrome Study Group","volume":"438","author":"Nelson","year":"1998","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.rdc.2008.08.008_bib61","first-page":"s60","article-title":"Objective demonstration of tear stimulation with oral pilocarpine in dry eye patients","volume":"41","author":"Mathers","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.rdc.2008.08.008_bib62","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archinte.159.2.174","article-title":"Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjogren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group","volume":"159","author":"Vivino","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.rdc.2008.08.008_bib63","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/art.510","article-title":"A double-blind, randomized, placebo-controlled study of cevimeline in Sj\u00f6gren's syndrome patients with xerostomia and keratoconjunctivitis sicca","volume":"46","author":"Petrone","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2008.08.008_bib64","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/art.1780270415","article-title":"Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca","volume":"27","author":"Fox","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2008.08.008_bib65","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/bjo.83.4.390","article-title":"Treatment of dry eye by autologous serum application in Sj\u00f6gren's syndrome","volume":"83","author":"Tsubota","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.rdc.2008.08.008_bib66","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00004397-200010000-00009","article-title":"Serum application for treatment of ocular surface disease","volume":"40","author":"Tsubota","year":"2000","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.rdc.2008.08.008_bib67","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ajo.2006.05.002","article-title":"Is autologous serum a tonic for the ailing corneal epithelium?","volume":"142","author":"Pflugfelder","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.rdc.2008.08.008_bib68","doi-asserted-by":"crossref","first-page":"C595","DOI":"10.1152\/ajpcell.2001.281.2.C595","article-title":"Rabbit conjunctival epithelium transports fluid, and P2Y2(2) receptor agonists stimulate Cl (\u2013) and fluid secretion","volume":"281","author":"Li","year":"2001","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.rdc.2008.08.008_bib69","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1097\/01.ico.0000133993.14768.a9","article-title":"Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye","volume":"23","author":"Tauber","year":"2004","journal-title":"Cornea"},{"key":"10.1016\/j.rdc.2008.08.008_bib70","unstructured":"Donshik PC, et al. Association for Research in Vision and Ophthalmology Annual Meeting. Fort Lauderdale (FL), April 30\u2013May 4, 2006."},{"key":"10.1016\/j.rdc.2008.08.008_bib71","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.286.17.2114","article-title":"Hormone replacement therapy and dry eye syndrome","volume":"286","author":"Schaumberg","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.rdc.2008.08.008_bib72","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.ajo.2004.11.042","article-title":"Combined esterified estrogen and methyltestosterone treatment for dry eye syndrome in postmenopausal women","volume":"139","author":"Scott","year":"2005","journal-title":"Am J\u00a0Ophthalmol"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X08000793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X08000793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:08:47Z","timestamp":1760180927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X08000793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":72,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0889857X08000793"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2008.08.008","relation":{},"ISSN":["0889-857X"],"issn-type":[{"type":"print","value":"0889-857X"}],"subject":[],"published":{"date-parts":[[2008,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Dry Eye Disease by the Non-Ophthalmologist","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2008.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}